Blue Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.39K Buy
+26
New +$1.17K ﹤0.01% 2112
2025
Q4
– Sell
-32
Closed -$889 – 2540
2025
Q3
$889 Buy
+32
New +$809 ﹤0.01% 2348
2024
Q4
– Sell
-267
Closed -$6.27K – 2462
2024
Q3
$6.27K Hold
267
– – ﹤0.01% 2342
2024
Q2
$7.68K Hold
267
– – ﹤0.01% 2029
2024
Q1
$7.68K Hold
267
– – ﹤0.01% 1515
2023
Q4
$7K Hold
267
– – ﹤0.01% 1694
2023
Q3
$9K Hold
267
– – ﹤0.01% 1428
2023
Q2
$8K Hold
267
– – ﹤0.01% 1365
2023
Q1
$8K Sell
267
-228
-46% -$7.06K ﹤0.01% 1652
2022
Q4
$16K Hold
495
– – ﹤0.01% 1367
2022
Q3
$15K Hold
495
– – ﹤0.01% 1191
2022
Q2
$22K Buy
+495
New +$17.3K ﹤0.01% 918

Other funds holding ARKG

Blue Trust's ARKG Position: Q3 2026 in Review

Blue Trust opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 26 shares worth $1.39K. The stake represents ﹤0.01% of the portfolio and ranks #2112 among its holdings. This is a return to the name: Blue Trust previously reported a position in ARKG as recently as Q3 2025.

Blue Trust first reported a position in ARKG in Q2 2022 and has held it in 12 quarters since. The position peaked at $22K in Q2 2022. 268 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • Blue Trust held 26 shares of ARK Genomic Revolution ETF worth $1.39K as of Q3 2026.
  • ARK Genomic Revolution ETF was a new Blue Trust position in Q3 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2112 holding.
  • Blue Trust first reported a position in ARK Genomic Revolution ETF in Q2 2022 and has held it in 12 quarters since.
  • Blue Trust's ARK Genomic Revolution ETF position peaked at $22K in Q2 2022.
  • 268 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.